Clinical Trial Imaging Market Size, Share & Trends Analysis Report By Modality (Computed Tomography Scan, Magnetic Resonance Imaging), By Therapeutic Area, By Services, By End Use, Region, And Segment Forecasts, 2025 - 2030
Diabetic Footwear Market Growth & Trends
The global diabetic footwear market size is expected to reach USD 13.98 billion by 2030, according to a new report by Grand View Research, Inc. It is projected to expand at a CAGR of 7.7% from 2025 to 2030. Rising importance of specialty footwear which improve the lower body posture and protect the feet from fungal infection is expected to remain a favorable factor. Furthermore, rising concerns over adverse effects associated with obesity are expected to promote the use of diabetic footwear as a preventive measure.
Shoes are expected to generate a revenue of USD 4.68 billion by 2030. The segment is expected to lead the market in light of its increased utility among office-going population. Furthermore, fluctuating diet patterns and hectic lifestyle among middle class population in emerging economies including China and India is expected to encourage consumers to use diabetic shoes as a regular footwear option.
Diabetic Footwear Market Report Highlights
- The sandal segment is expected to grow at a significant CAGR during the forecast period, owing to increased usage of these products as casual footwear by people in the age group of 45+ in developed economies including Germany and U.K.
- Slippers generated a revenue of USD 3.22 billion in 2024. The segment is expected to hold more than 36.0% of global market share on account of predominant usage as daily home footwear among health conscious consumers
- Online segment is expected to remain the most lucrative distribution channel over the next eight years. These channels are expected to remain a preferred choice on account of various value-added benefits including cash benefits and free-home delivery by the footwear companies and e-commerce portals
- The North American diabetic footwear market secured the dominant market revenue share of 33.5% in 2024.
- The diabetic footwear market is highly competitive in nature with the main players including DJO Global Inc.; Drew Shoes; I-Runner; and Dr. Zen Products, Inc. Various manufacturers are concentrating on new product launches, capacity expansion, and technological innovation to cater to the existing and future demand from new application segments.
- Chapter 1. Methodology and Scope
- 1.1. Market Segmentation and Scope
- 1.2. Segment Definitions
- 1.2.1. Modality
- 1.2.2. Therapeutic Area
- 1.2.3. Services
- 1.2.4. End Use
- 1.2.5. Estimates and forecasts timeline
- 1.3. Research Methodology
- 1.4. Information Procurement
- 1.4.1. Purchased database
- 1.4.2. GVR’s internal database
- 1.4.3. Secondary sources
- 1.4.4. Primary research
- 1.4.5. Details of primary research
- 1.4.5.1. Data for primary interviews in North America
- 1.4.5.2. Data for primary interviews in Europe
- 1.4.5.3. Data for primary interviews in Asia Pacific
- 1.4.5.4. Data for primary interviews in Latin America
- 1.4.5.5. Data for Primary interviews in MEA
- 1.5. Information or Data Analysis
- 1.5.1. Data analysis models
- 1.6. Market Formulation & Validation
- 1.7. Model Details
- 1.7.1. Commodity flow analysis (Model 1)
- 1.7.2. Approach 1: Commodity flow approach
- 1.7.3. Volume price analysis (Model 2)
- 1.7.4. Approach 2: Volume price analysis
- 1.8. List of Secondary Sources
- 1.9. List of Primary Sources
- 1.10. Objectives
- Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Modality outlook
- 2.2.2. Therapeutic area outlook
- 2.2.3. Services outlook
- 2.2.4. End Use outlook
- 2.3. Regional outlook
- 2.4. Competitive Insights
- Chapter 3. Clinical Trial Imaging Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Related/ancillary market outlook
- 3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.1.1. Growing number of pharmaceutical and biotechnological companies
- 3.2.1.2. Growing number of contract research organization (CRO)
- 3.2.1.3. Increasing research and development investments
- 3.2.2. Market Restraint Analysis
- 3.2.2.1. High cost of machineries and installations
- 3.3. Clinical Trial Imaging Market Analysis Tools
- 3.3.1. Industry Analysis - Porter’s
- 3.3.1.1. Bargaining power of suppliers
- 3.3.1.2. Bargaining power of buyers
- 3.3.1.3. Threat of substitutes
- 3.3.1.4. Threat of new entrants
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
- 3.3.2.1. Political landscape
- 3.3.2.2. Economic landscape
- 3.3.2.3. Social landscape
- 3.3.2.4. Technological landscape
- 3.3.2.5. Environmental landscape
- 3.3.2.6. Legal landscape
- Chapter 4. Clinical Trial Imaging Market: Modality Estimates & Trend Analysis
- 4.1. Segment Dashboard
- 4.2. Clinical Trial Imaging Market: Modality Movement Analysis
- 4.3. Clinical Trial Imaging Market by Modality Outlook (USD Million)
- 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 4.5. Computed Tomography Scan
- 4.5.1. Computed Tomography Scan Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.6. Magnetic Resonance Imaging
- 4.6.1. Magnetic Resonance Imaging Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.7. X-Ray
- 4.7.1. X-Ray Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.8. Ultrasound
- 4.8.1. Ultrasound Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.9. Optical Coherence Tomography (OCT)
- 4.9.1. Optical Coherence Tomography (OCT) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.10. Other Modalities
- 4.10.1. Other Modalities Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- Chapter 5. Clinical Trial Imaging Market: Therapeutic Area Estimates & Trend Analysis
- 5.1. Segment Dashboard
- 5.2. Clinical Trial Imaging Market: Therapeutic Area Movement Analysis
- 5.3. Clinical Trial Imaging Market by Therapeutic Area Outlook (USD Million)
- 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 5.5. Neurovascular Diseases
- 5.5.1. Neurovascular Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.6. Cardiovascular Diseases
- 5.6.1. Cardiovascular Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.7. Orthopedics & MSK Disorders
- 5.7.1. Orthopedics & MSK Disorders Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.8. Oncology
- 5.8.1. Oncology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.9. Ophthalmology
- 5.9.1. Ophthalmology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.10. Nephrology
- 5.10.1. Nephrology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.11. Other Therapeutic Areas
- 5.11.1. Other Therapeutic Areas Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- Chapter 6. Clinical Trial Imaging Market: Services Estimates & Trend Analysis
- 6.1. Segment Dashboard
- 6.2. Clinical Trial Imaging Market: Services Movement Analysis
- 6.3. Clinical Trial Imaging Market by Services Outlook (USD Million)
- 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 6.5. Clinical Trial Design and Consultation Services
- 6.5.1. Clinical Trial Design and Consultation Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.6. Reading and Analytical Services
- 6.6.1. Reading and Analytical Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.7. Operational Imaging Services
- 6.7.1. Operational Imaging Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.8. System and Technology Support Services
- 6.8.1. System and Technology Support Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.9. Project and Data Management
- 6.9.1. Project and Data Management Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- Chapter 7. Clinical Trial Imaging Market: End Use Estimates & Trend Analysis
- 7.1. Segment Dashboard
- 7.2. Clinical Trial Imaging Market: End Use Movement Analysis
- 7.3. Clinical Trial Imaging Market by End Use Outlook (USD Million)
- 7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 7.5. Biotechnology and Pharmaceutical Companies
- 7.5.1. Biotechnology and Pharmaceutical Companies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6. Medical Devices Manufacturers
- 7.6.1. Medical Devices Manufacturers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.7. Academic and Government Research Institutes
- 7.7.1. Academic and Government Research Institutes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.8. Contract Research Organizations (CROs)
- 7.8.1. Contract Research Organizations (CROs) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.9. Other End Users
- 7.9.1. Other End Users Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- Chapter 8. Clinical Trial Imaging Market: Regional Estimates & Trend Analysis
- 8.1. Regional Market Share Analysis, 2024 & 2030
- 8.2. Regional Market Dashboard
- 8.3. Global Regional Market Snapshot
- 8.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
- 8.5. North America
- 8.5.1. U.S.
- 8.5.1.1. Key country dynamics
- 8.5.8.2. Regulatory framework/ reimbursement structure
- 8.5.1.3. Competitive scenario
- 8.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
- 8.5.2. Canada
- 8.5.2.1. Key country dynamics
- 8.5.2.2. Regulatory framework/ reimbursement structure
- 8.5.2.3. Competitive scenario
- 8.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
- 8.5.3. Mexico
- 8.5.3.1. Key country dynamics
- 8.5.3.2. Regulatory framework/ reimbursement structure
- 8.5.3.3. Competitive scenario
- 8.5.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
- 8.6. Europe
- 8.6.1. UK
- 8.6.1.1. Key country dynamics
- 8.6.1.2. Regulatory framework/ reimbursement structure
- 8.6.1.3. Competitive scenario
- 8.6.8.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
- 8.6.2. Germany
- 8.6.2.1. Key country dynamics
- 8.6.2.2. Regulatory framework/ reimbursement structure
- 8.6.2.3. Competitive scenario
- 8.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
- 8.6.3. France
- 8.6.3.1. Key country dynamics
- 8.6.3.2. Regulatory framework/ reimbursement structure
- 8.6.3.3. Competitive scenario
- 8.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
- 8.6.4. Italy
- 8.6.4.1. Key country dynamics
- 8.6.4.2. Regulatory framework/ reimbursement structure
- 8.6.4.3. Competitive scenario
- 8.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
- 8.6.5. Spain
- 8.6.5.1. Key country dynamics
- 8.6.5.2. Regulatory framework/ reimbursement structure
- 8.6.5.3. Competitive scenario
- 8.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
- 8.6.6. Norway
- 8.6.6.1. Key country dynamics
- 8.6.6.2. Regulatory framework/ reimbursement structure
- 8.6.6.3. Competitive scenario
- 8.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
- 8.6.7. Sweden
- 8.6.7.1. Key country dynamics
- 8.6.7.2. Regulatory framework/ reimbursement structure
- 8.6.7.3. Competitive scenario
- 8.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
- 8.6.8. Denmark
- 8.6.8.1. Key country dynamics
- 8.6.8.2. Regulatory framework/ reimbursement structure
- 8.6.8.3. Competitive scenario
- 8.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
- 8.7. Asia Pacific
- 8.7.8. Japan
- 8.7.1.1. Key country dynamics
- 8.7.1.2. Regulatory framework/ reimbursement structure
- 8.7.1.3. Competitive scenario
- 8.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
- 8.7.2. China
- 8.7.2.1. Key country dynamics
- 8.7.2.2. Regulatory framework/ reimbursement structure
- 8.7.2.3. Competitive scenario
- 8.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
- 8.7.3. India
- 8.7.3.1. Key country dynamics
- 8.7.3.2. Regulatory framework/ reimbursement structure
- 8.7.3.3. Competitive scenario
- 8.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
- 8.7.4. Australia
- 8.7.4.1. Key country dynamics
- 8.7.4.2. Regulatory framework/ reimbursement structure
- 8.7.4.3. Competitive scenario
- 8.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
- 8.7.5. South Korea
- 8.7.5.1. Key country dynamics
- 8.7.5.2. Regulatory framework/ reimbursement structure
- 8.7.5.3. Competitive scenario
- 8.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
- 8.7.6. Thailand
- 8.7.6.1. Key country dynamics
- 8.7.6.2. Regulatory framework/ reimbursement structure
- 8.7.6.3. Competitive scenario
- 8.7.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
- 8.8. Latin America
- 8.8.1. Brazil
- 8.8.1.1. Key country dynamics
- 8.8.1.2. Regulatory framework/ reimbursement structure
- 8.8.1.3. Competitive scenario
- 8.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
- 8.8.2. Argentina
- 8.8.2.1. Key country dynamics
- 8.8.2.2. Regulatory framework/ reimbursement structure
- 8.8.2.3. Competitive scenario
- 8.8.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
- 8.9. Middle East & Africa
- 8.9.1. South Africa
- 8.9.1.1. Key country dynamics
- 8.9.1.2. Regulatory framework/ reimbursement structure
- 8.9.1.3. Competitive scenario
- 8.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
- 8.9.2. Saudi Arabia
- 8.9.2.1. Key country dynamics
- 8.9.2.2. Regulatory framework/ reimbursement structure
- 8.9.2.3. Competitive scenario
- 8.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
- 8.9.3. UAE
- 8.9.3.1. Key country dynamics
- 8.9.3.2. Regulatory framework/ reimbursement structure
- 8.9.3.3. Competitive scenario
- 8.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
- 8.9.4. Kuwait
- 8.9.4.1. Key country dynamics
- 8.9.4.2. Regulatory framework/ reimbursement structure
- 8.9.4.3. Competitive scenario
- 8.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
- Chapter 9. Competitive Landscape
- 9.1. Recent Developments & Impact Analysis, By Key Market Participants
- 9.1.1 Company/Competition Categorization
- 9.1.2. Innovators
- 9.2. Vendor Landscape
- 9.2.1. List of key distributors and channel partners
- 9.2.2. Key customers
- 9.2.3. Key company market share analysis, 2024
- 9.2.4. IXICO plc
- 9.2.4.1. Company overview
- 9.2.4.2. Financial performance
- 9.2.4.3. Product benchmarking
- 9.2.4.4. Strategic initiatives
- 9.2.5. Navitas Life Sciences
- 9.2.5.1. Company overview
- 9.2.5.2. Financial performance
- 9.2.5.3. Product benchmarking
- 9.2.5.4. Strategic initiatives
- 9.2.6. Resonance Health
- 9.2.6.1. Company overview
- 9.2.6.2. Financial performance
- 9.2.6.3. Product benchmarking
- 9.2.6.4. Strategic initiatives
- 9.2.7. ProScan Imaging
- 9.2.7.1. Company overview
- 9.2.7.2. Financial performance
- 9.2.7.3. Product benchmarking
- 9.2.7.4. Strategic initiatives
- 9.2.8. Radiant Sage LLC
- 9.2.8.1. Company overview
- 9.2.8.2. Financial performance
- 9.2.8.3. Product benchmarking
- 9.2.8.4. Strategic initiatives
- 9.2.9. Medpace
- 9.2.9.1. Company overview
- 9.2.9.2. Financial performance
- 9.2.9.3. Product benchmarking
- 9.2.9.4. Strategic initiatives
- 9.2.10. Biomedical Systems Corp.
- 9.2.10.1. Company overview
- 9.2.10.2. Financial performance
- 9.2.10.3. Product benchmarking
- 9.2.10.4. Strategic initiatives
- 9.2.11. Cardiovascular Imaging Technologies
- 9.2.11.1. Company overview
- 9.2.11.2. Financial performance
- 9.2.11.3. Product benchmarking
- 9.2.11.4. Strategic initiatives
- 9.2.12. Intrinsic Imaging
- 9.2.12.1. Company overview
- 9.2.12.2. Financial performance
- 9.2.12.3. Product benchmarking
- 9.2.12.4. Strategic initiatives
- 9.2.13. BioTelemetry
- 9.2.13.1. Company overview
- 9.2.13.2. Financial performance
- 9.2.13.3. Product benchmarking
- 9.2.13.4. Strategic initiatives
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook